Short Bets on Palantir, Rocket Lab, MSTR Top S&P 500 in June
Leveraged short funds targeting Palantir, Rocket Lab, and Strategy surged as much as 130% in June, outpacing every S&P 500 stock.
Bearish traders scored massive wins in June, with leveraged short funds betting against Palantir, Rocket Lab, and Strategy — the company formerly known as MicroStrategy — posting gains of up to 130%, a performance that dwarfed every single stock in the S&P 500 over the same period.
The trades represent some of the most aggressive contrarian positions available to retail and institutional investors alike. Leveraged inverse funds amplify daily moves against a target stock, meaning a sustained decline in the underlying shares can produce outsized, rapid returns — but the same mechanics can generate severe losses if the bet moves the wrong way.
Read more Charter Communications Leads S&P 500 Gains Amid SpaceX, Comcast Shifts →
Palantir, Rocket Lab, and Strategy had each attracted significant bullish attention heading into the summer, making them prime targets for short sellers looking to fade high-multiple, momentum-driven names. When those stocks pulled back, the inverse leveraged products tied to them exploded higher, turning what many considered speculative short positions into June's standout performers.
The dominance of these short trades over every long position in the S&P 500 underscores how volatile the broader market environment remained in June, with even well-known growth names proving vulnerable to sharp reversals. Analysts often caution that leveraged short funds are designed for short-term tactical use and carry compounding risks that make them unsuitable for buy-and-hold strategies.
Continue reading at Benzinga.
